{"id":10970,"date":"2026-03-06T23:02:28","date_gmt":"2026-03-06T23:02:28","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/03\/06\/fda-vinay-prasad-controversial-cber-director-leaving\/"},"modified":"2026-03-06T23:02:28","modified_gmt":"2026-03-06T23:02:28","slug":"fda-vinay-prasad-controversial-cber-director-leaving","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/03\/06\/fda-vinay-prasad-controversial-cber-director-leaving\/","title":{"rendered":"Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency"},"content":{"rendered":"<p>    Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>WASHINGTON \u2014 Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time.<\/p>\n<p>Prasad will leave the FDA at the end of April, and his replacement has not yet been identified, FDA Commissioner Marty Makary <a href=\"https:\/\/www.wsj.com\/health\/healthcare\/fdas-controversial-vaccines-chief-will-leave-the-agency-7fe59aa3\">told The Wall Street Journal<\/a>.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2026\/03\/06\/fda-vinay-prasad-controversial-cber-director-leaving\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Lizzy Lawrence<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2026\/03\/06\/fda-vinay-prasad-controversial-cber-director-leaving\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency WASHINGTON \u2014 Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave the FDA at the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2216,2208,2146,2147,2151,2144,2185],"tags":[2150],"class_list":["post-10970","post","type-post","status-publish","format-standard","hentry","category-breaking-news","category-drug-development","category-fda","category-hhs","category-policy","category-politics","category-white-house","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10970"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=10970"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10970\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=10970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=10970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=10970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}